[1]Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people and implications for health policy and practice. Lancet 2015;385:549-562.
[2]Vermunt L, Sikkes SAM, van den Hout A, et al. Alzheimer disease neuroimaging initiative; AIBL Research Group; ICTUS/DSA study groups. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimers Dement 2019; pii: S1552-5260(19)30084-6.
[3]Dekhtyar S, Marseglia A, Xu W, et al. Genetic risk of dementia mitigated by cognitive reserve: A cohort study. Ann Neurol. 2019; doi: 10.1002/ana.25501.
[4]Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet 2017;390:2673-2734.
[5]Ott A, Slooter AJ, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998;351:1840-1843.
[6]Choi D, Choi S, Park SM. Effect of smoking cessation on the risk of dementia: a longitudinal study. Ann Clin Transl Neurol 2018;5:1192-1199.
[7]Albanese E, Launer LJ, Egger M, et al. Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst). 2017;8:165-178.
[8]Bowman K, Thambisetty M, Kuchel GA, et al. Obesity and longer term risks of dementia in 65-74 year olds. Age Ageing 2019;48:367-373.
[9]Shie HG, Li CY. Population-based case-control study of risk factors for unintentional mortality from carbon monoxide poisoning in Taiwan. Inhal Toxicol. 2007;19:905-912.
[10]Eichhorn L, Thudium M, Jüttner B. The diagnosis and treatment of carbon monoxide poisoning. Dtsch Arztebl Int. 2018;115:863-870.
[11]Gunnell D, Coope C, Fearn V, et al. Suicide by gases in England and Wales 2001-2011: evidence of the emergence of new methods of suicide. J Affect Disord 2015;170:190-195.
[12]Choi IS. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983;40:433-435.
[13]Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
[14]Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
[15]Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
[16]Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
[17]Lai CY, Huang YW, Tseng CH, et al. Patients With Carbon Monoxide Poisoning and Subsequent Dementia: A Population-Based Cohort Study. Medicine (Baltimore) 2016;95:e2418.
[18]Wong CS, Lin YC, Hong LY, et al. Increased Long-Term Risk of Dementia in Patients With Carbon Monoxide Poisoning: A Population-Based Study. Medicine (Baltimore) 2016;95:e2549.
[19]Chang SY, Chien WC, Chung CH, et al. Risk of dementia after charcoal-burning suicide attempts: a nationwide cohort study in Taiwan. J Investig Med 2018;66:1070-1082.
[20]Weaver LK. Clinical practice. Carbon monoxide poisoning. N Engl J Med 2009;
360:1217-1225.
[21]Hopkins RO, Weaver LK, Valentine KJ, et al. Apolipoprotein E genotype and
response of carbon monoxide poisoning to hyperbaric oxygen treatment. Am J
Respir Crit Care Med 2007;176:1001-1006.
[22]Rodríguez JJL, Cepero AV, Gil IYS, et al. Incidence of dementia and association
with APOE genotype in older Cubans. Dement Neuropsychol 2014;8:356-363.
[23]Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
[24] Jeon SB, Sohn CH, Seo DW, et al. Acute brain lesions on magnetic resonance imaging and delayed neurological sequelae in carbon monoxide poisoning. JAMA Neurol 2018;75:436-443.
[25] Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002;347:1057-1067.
[26]Hopkins RO, Weaver LK. Cognitive outcomes 6 years after acute carbon monoxide poisoning. Undersea Hyperb Med. 2008;35:258.
[27]Weaver LK, Hopkins RO, Churchill S, et al. Neurological outcomes 6 years after acute carbon monoxide poisoning. Undersea Hyperb Med. 2008;35:258-259.
[28]Shie HG, Li CY. Population-based case-control study of risk factors for unintentional mortality from carbon monoxide poisoning in Taiwan. Inhal Toxicol. 2007;19:905-912.
[29]Chang SS, Chen YY, Yip PS, et al. Regional changes in charcoal-burning suicide rates in East/Southeast Asia from 1995 to 2011: a time trend analysis. PLoS Med 2014;11:e1001622.
[30]Chen YY, Yip PS, Lee CK, et al. The diffusion of a new method of suicide: charcoal-burning suicide in Hong Kong and Taiwan. Soc Psychiatry Psychiatr Epidemiol 2015;50:227-236.
[31]Rose JJ, Wang L, Xu Q, et al. Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy. Am J Respir Crit Care Med. 2017;195:596-606.
[32]Grim PS, Gottlieb LJ, Boddie A, et al. Hyperbaric oxygen therapy. JAMA 1990; 263:2216-2220.
[33]Pace N, Strajman E, Walker EL. Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science 1950;111:652-654.
[34]Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002;347:1057-1067.
[35]Liu WC, Yang SN, Wu CW, et al. Hyperbaric oxygen therapy alleviates carbon monoxide poisoning-induced delayed memory impairment by preserving brain-derived neurotrophic factor-dependent hippocampal neurogenesis. Crit Care Med 2016;44:e25-39.
[36]Lin CH, Su WH, Chen YC, et al. Treatment with normobaric or hyperbaric oxygen and its effect on neuropsychometric dysfunction after carbon monoxide poisoning: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2018;97:e12456.
[37]Nakajima M, Aso S, Matsui H, et al. Hyperbaric oxygen therapy and mortality from carbon monoxide poisoning: A nationwide observational study. Am J Emerg Med. 2019;pii: S0735-6757(19)30087-7.
[38]Huang CC, Ho CH, Chen YC, et al. Hyperbaric oxygen therapy is associated with lower short- and long-term mortality in patients with carbon monoxide poisoning. Chest 2017;152:943-953.
[39]Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust 1999;170:203.
[40]Weaver LK, Valentine KJ, Hopkins RO. Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med 2007;176:491-497.
[41]Hopkins RO, Weaver LK, Valentine KJ, et al. Apolipoprotein E genotype and response of carbon monoxide poisoning to hyperbaric oxygen treatment. Am J Respir Crit Care Med 2007;176:1001-1006.